Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Raimondi

Showing results (361-370 of 399) with videos related to

Pageof 40
Sort By:
Leukemia|June 8, 2011
IDH1 and IDH2 mutations in pediatric acute leukemiaA K Andersson, D W Miller, J A Lynch, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2009
Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemiaIna Radtke, Charles G Mullighan, Masami Ishii, et al.
Blood|July 1, 2004
Gene expression profiling of pediatric acute myelogenous leukemiaMary E Ross, Rami Mahfouz, Mihaela Onciu, et al.
The Lancet. Oncology|May 11, 2010
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trialJeffrey E Rubnitz, Hiroto Inaba, Gary Dahl, et al.
Blood|July 15, 2004
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research HospitalChing-Hon Pui, John T Sandlund, Deqing Pei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2014
Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual diseaseKathryn G Roberts, Deqing Pei, Dario Campana, et al.
Leukemia|August 26, 2016
Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapyC-H Pui, D Pei, S C Raimondi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2019
Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16Sima Jeha, Deqing Pei, John Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Comparative analysis of different approaches to measure treatment response in acute myeloid leukemiaHiroto Inaba, Elaine Coustan-Smith, Xueyuan Cao, et al.
Leukemia|August 27, 2011
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapyD Bhojwani, D Pei, J T Sandlund, et al.
Pageof 40

Showing results (361-370 of 399) with videos related to

Sort By:
Pageof 40
Leukemia|June 8, 2011
IDH1 and IDH2 mutations in pediatric acute leukemiaA K Andersson, D W Miller, J A Lynch, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2009
Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemiaIna Radtke, Charles G Mullighan, Masami Ishii, et al.
Blood|July 1, 2004
Gene expression profiling of pediatric acute myelogenous leukemiaMary E Ross, Rami Mahfouz, Mihaela Onciu, et al.
The Lancet. Oncology|May 11, 2010
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trialJeffrey E Rubnitz, Hiroto Inaba, Gary Dahl, et al.
Blood|July 15, 2004
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research HospitalChing-Hon Pui, John T Sandlund, Deqing Pei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2014
Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual diseaseKathryn G Roberts, Deqing Pei, Dario Campana, et al.
Leukemia|August 26, 2016
Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapyC-H Pui, D Pei, S C Raimondi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2019
Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16Sima Jeha, Deqing Pei, John Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Comparative analysis of different approaches to measure treatment response in acute myeloid leukemiaHiroto Inaba, Elaine Coustan-Smith, Xueyuan Cao, et al.
Leukemia|August 27, 2011
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapyD Bhojwani, D Pei, J T Sandlund, et al.
Pageof 40